4.7 Article

CUR-N399, a PI4KB inhibitor, for the treatment of Enterovirus A71 infection

期刊

ANTIVIRAL RESEARCH
卷 218, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.antiviral.2023.105713

关键词

Enterovirus A71; HFMD; CUR-N399; PI4KB inhibitor; Infection; Antiviral

向作者/读者索取更多资源

Hand, foot and mouth disease (HFMD) is a common disease that mainly affects young children. This study discovers a broad-spectrum antiviral inhibitor called CUR-N399, which shows therapeutic effects against enterovirus A71 (EV-A71) infection in mice.
Over the years, the hand, foot and mouth disease (HFMD) has sparked epidemics across many countries which mainly affected young children. While symptoms are usually mild, severe complications may arise, and some even lead to death. Such concerns, coupled with the lack of approved vaccines and antivirals to date, create an urgency in the identification of safe therapeutics against HFMD. The disease is mainly transmitted by enteroviruses like enterovirus A71 (EV-A71). Essential for enterovirus replication is the host protein, PI4KB. In this study, we investigate the antiviral efficacy of a novel PI4KB inhibitor, CUR-N399. We found that CUR-N399 displayed broad-spectrum antiviral activity against picornaviruses in cell culture models. Using a suckling mouse model of lethal EV-A71 infection, CUR-N399 was found to be well-tolerated, promote survival and reduce viral titre in mice organs. Together, these support the discovery of CUR-N399 as an antiviral against EV-A71 and potentially other closely related viruses.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据